2,984
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Ultrasonically controlled albumin-conjugated liposomes for breast cancer therapy

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 705-714 | Received 30 Sep 2018, Accepted 20 Dec 2018, Published online: 15 Mar 2019

References

  • McKnight JA. Principles of chemotherapy. Clin Tech Small Anim Pract. 2003;18:67–72.
  • Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine. 2006;1:297–315.
  • Bhushan B, Khanadeev V, Khlebtsov B, et al. Impact of albumin based approaches in nanomedicine: imaging, targeting and drug delivery. Adv Colloid Interface Sci. 2017;246:13–39.
  • Maeda H, Wu J, Sawa T, et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65:271–284.
  • Cattel L, Ceruti M, Dosio F. From conventional to stealth liposomes: a new frontier in cancer chemotherapy. Tumori. 2003;89:237–249.
  • Hu CM, Kaushal S, Tran Cao HS, et al. Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells. Mol Pharm. 2010;7:914–920.
  • Merlot AM, Kalinowski DS, Richardson DR. Unraveling the mysteries of serum albumin-more than just a serum protein. Front Physiol. 2014;5:299.
  • Stehle G, Sinn H, Wunder A, et al. Plasma protein (albumin) catabolism by the tumor itself–implications for tumor metabolism and the genesis of cachexia. Crit Rev Oncol Hematol. 1997;26:77–100.
  • Soreide JA, Lea OA, Kvinnsland S. Cytosol protein content and prognosis in operable breast cancer. Breast Cancer Res Tr. 1991;20:25–32.
  • Satoh H, Kamma H, Ishikawa H, et al. Expression of hnRNP A2/B1 proteins in human cancer cell lines. Int J Oncol. 2000;16:763–767.
  • Sueoka E, Goto Y, Sueoka N, et al. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers. Cancer Res. 1999;59:1404–1407.
  • Stehle G, Sinn H, Wunder A, et al. The loading rate determines tumor targeting properties of methotrexate-albumin conjugates in rats. Anticancer Drugs. 1997;8:677–685.
  • Germain P, Metezeau P, Hellio R, et al. Internalization and biological effects of serum albumin in the breast cancer MCF-7 and MDA-MB 231 cells. Cell Mol Biol (Noisy-le-Grand). 1995;41:1119–1129.
  • Furumoto K, Yokoe J, Ogawara K, et al. Effect of coupling of albumin onto surface of PEG liposome on its in vivo disposition. Int J Pharm. 2007;329:110.
  • Manzoor AA, Lindner LH, Landon CD, et al. Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. Cancer Res. 2012;72:5566–5575.
  • El-Kareh AW, Secomb TW. A mathematical model for comparison of bolus injection, continuous infusion, and liposomal delivery of doxorubicin to tumor cells. Neoplasia. 2000;2:325–338.
  • Turk MJ, Reddy JA, Chmielewski JA, et al. Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs. Biochim Biophys Acta. 2002;1559:56–68.
  • O’Brien DF, Whitesides TH, Klingbiel RT. The photopolymerization of lipid-diacetylenes in bimolecular-layer membranes. J Polym Sci B Polym Lett Ed. 1981;19:95–101.
  • Zhu L, Kate P, Torchilin VP. Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. ACS Nano. 2012;6:3491–3498.
  • Needham D, Anyarambhatla G, Kong G, et al. A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res. 2000;60:1197–1201.
  • Lin HY, Thomas JL. PEG − lipids and oiligo(ethylene glycol) surfactants enhance the ultrasonic permeabilizability of liposomes. Langmuir. 2003;19:1098–1105.
  • Ahmed SE, Awad N, Paul V, et al. Improving the efficacy of anticancer drugs via encapsulation and acoustic release. Curr Top Med Chem. 2018;18:857–880.
  • Evjen TJ, Nilssen EA, Rognvaldsson S, et al. Distearoylphosphatidylethanolamine-based liposomes for ultrasound-mediated drug delivery. Eur J Pharm Biopharm. 2010;75:327–333.
  • Moussa HG, Martins AM, Husseini GA. Review on triggered liposomal drug delivery with a focus on ultrasound. Curr Cancer Drug Targets. 2015;15:282–313.
  • Lasch J, Weissig V, Brandl M. Preparation of liposomes. 2nd ed. In: Torchilin VP, Weissig V, editors. Liposomes—a practical approach. New York (NY): Oxford University Press; 2003. p. 3–30.
  • Husseini GA, Christensen DA, Rapoport NY, et al. Ultrasonic release of doxorubicin from Pluronic P105 micelles stabilized with an interpenetrating network of N,N-diethylacrylamide. J Control Release. 2002;83:303–305.
  • Kost J, Leong K, Langer R. Ultrasound-enhanced polymer degradation and release of incorporated substances. Proc Natl Acad Sci USA. 1989;86:7663–7666.
  • Kinoshita M, Hynynen K. A novel method for the intracellular delivery of siRNA using microbubble-enhanced focused ultrasound. Biochem Biophys Res Commun. 2005;335:393–399.
  • Schroeder A, Avnir Y, Weisman S, et al. Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility. Langmuir. 2007;23:4019–4025.
  • Delalande A, Kotopoulis S, Postema M, et al. Sonoporation: mechanistic insights and ongoing challenges for gene transfer. Gene. 2013;525:191–199.
  • Levi C. Ultrasound for targeted delivery of cytotoxic drugs from liposomes [M.Sc. thesis]. Beer Sheva, Israel: Ben Gurion University; 2000.
  • Schroeder A, Kost J, Barenholz Y. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes. Chem Phys Lipids. 2009;162:1–16.
  • Maynard VM, Magin R, Strom-Jensen P R, et al. Ultrasonic absorption by liposomes. In Ultrasonic Symposium. Vol. 2; 1983. p. 806–809.
  • Tata DB, Dunn F. Interaction of ultrasound and model membrane systems: analyses and predictions. J Phys Chem. 1992;96:3548–3555.
  • Evjen TJ, Hupfeld S, Barnert S, et al. Physicochemical characterization of liposomes after ultrasound exposure - mechanisms of drug release. J Pharm Biomed Anal. 2013;78–79:118–122.
  • Ickenstein LM, Arfvidsson MC, Needham D, et al. Disc formation in cholesterol-free liposomes during phase transition. Biochim Biophys Acta. 2003;1614:135–138.
  • Im J, Maiti K K, Kim W, et al. Cellular uptake properties of the complex derived from quantum dots and G8 molecular transporter. Bull Korean Chem Soc. 2011;32:1282–1292.
  • Kumari S, Mg S, Mayor S. Endocytosis unplugged: multiple ways to enter the cell. Cell Res. 2010;20:256–275.
  • Parton RG, Simons K. The multiple faces of caveolae. Nat Rev Mol Cell Biol. 2007;8:185–194.
  • Cokakli M, Erdal E, Nart D, et al. Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion. BMC Cancer. 2009;9:65–65.
  • Chatterjee M, Ben-Josef E, Robb R, et al. Caveolae-mediated endocytosis is critical for albumin cellular uptake and response to albumin-bound chemotherapy. Cancer Res. 2017;77:5925–5937.
  • John TA, Vogel SM, Tiruppathi C, et al. Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer. Am J Physiol Lung Cell Mol Physiol. 2003;284:L187–L196.
  • Jiang Y, Wong S, Chen F, et al. Influencing selectivity to cancer cells with mixed nanoparticles prepared from albumin–polymer conjugates and block copolymers. Bioconjugate Chem. 2017;28:979–985.
  • Voigt J, Christensen J, Shastri VP. Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae. Proc Natl Acad Sci. 2014;111:2942.
  • Sharma DK, Brown JC, Choudhury A, et al. Selective stimulation of caveolar endocytosis by glycosphingolipids and cholesterol. Mol Biol Cell. 2004;15:3114–3122.
  • Tachibana K, Uchida T, Ogawa K, et al. Induction of cell-membrane porosity by ultrasound. Lancet. 1999;353:1409.
  • Jelenc J, Miklavčič D, Lebar AM, editors. Low-frequency ultrasound in vitro: experimental system and ultrasound-induced changes of cell morphology. 2013 36th international convention on information and communication technology, electronics and microelectronics (MIPRO); 2013 May 20–24; Piscataway, NJ, IEEE.
  • Zarnitsyn V, Rostad CA, Prausnitz MR. Modeling transmembrane transport through cell membrane wounds created by acoustic cavitation. Biophys J. 2008;95:4124.
  • Zhang JZ, Saggar JK, Zhou ZL, et al. Different effects of sonoporation on cell morphology and viability. Bosn J Basic Med Sci. 2012;12:64–68.
  • Salkho NM, Paul V, Kawak P, et al. Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy. Artif Cells Nanomed Biotechnol. 2018;12:1–11.